Reviva Pharmaceuticals Holdings (RVPH) Common Equity (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) reported Common Equity of $15.21 million for Q2 2026, compared with -$459,147 a year earlier and down 12.8% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Reviva Pharmaceuticals Holdings posted Common Equity of $8.65 million, up 964.2% from FY2024.
- Common Equity has a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- By year, Common Equity came in at $812,572 in FY2024 (-85.8%), $5.72 million in FY2023 (-31.9%) and $8.39 million in FY2022.
- Five-year quarterly Common Equity spans a low of -$12.81 million in Q3 2023 and a high of $32.27 million in Q3 2021.
- The high point for year-over-year Common Equity in five years was Q4 2025 (growth of 964.2%); the low point was Q1 2023 (a decline of 92.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $17.44 million (Q1 2026), $8.65 million (Q4 2025) and $4.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Reviva Pharmaceuticals Holdings | 6.16 Mn | 6.16 Mn | - | 15.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.21 Mn |
| Mar 31, 2026 | 17.44 Mn |
| Dec 31, 2025 | 8.65 Mn |
| Sep 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | -459,147.00 |
| Mar 31, 2025 | -4.46 Mn |
| Dec 31, 2024 | 812,572.00 |
| Sep 30, 2024 | -9.98 Mn |
| Jun 30, 2024 | -6.04 Mn |
| Mar 31, 2024 | -1.35 Mn |
| Dec 31, 2023 | 5.72 Mn |
| Sep 30, 2023 | -12.81 Mn |
| Jun 30, 2023 | -1.82 Mn |
| Mar 31, 2023 | 1.61 Mn |
| Dec 31, 2022 | 8.39 Mn |
| Sep 30, 2022 | 17.56 Mn |
| Jun 30, 2022 | 16.06 Mn |
| Mar 31, 2022 | 21.36 Mn |
| Dec 31, 2021 | 28.69 Mn |
| Sep 30, 2021 | 32.27 Mn |
API Access
Reviva Pharmaceuticals Holdings Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();